What's Happening?
Researchers at the Institute for Human & Machine Cognition (IHMC) are conducting a new NIH-funded study, BOOST-X, to investigate whether adding a nitrate supplement to endurance and resistance training can further reduce all-cause mortality risk and reverse
hallmarks of aging in adults over 59. This study builds on their ongoing five-year clinical trial, M³AX, which aims to demonstrate exercise's ability to improve healthspan and quality of life. Dr. Marcas Bamman, Senior Research Scientist at IHMC and Director of Healthspan, Resilience and Performance Research, leads the BOOST-X trial. The study will be a randomized, double-blind, placebo-controlled trial, with participants receiving either a nitrate supplement (beetroot juice) or a placebo. The goal is to enhance vascular and cardiorespiratory function, improve mitochondrial function, reduce inflammation, and lower oxidative stress, particularly for older adults who may have reduced nitric oxide synthesis and stiff arteries. The multi-site trial, involving the University of Colorado in Boulder and the University of Maryland College of Medicine in Baltimore, seeks to ensure broader applicability of its findings.
Why It's Important?
This research holds significant importance for public health in the U.S., particularly for the aging population. As individuals age, their risk of all-cause mortality increases due to various factors like heart disease, strokes, cancer, and accidental falls. If the BOOST-X trial successfully demonstrates that a nitrate supplement, combined with exercise, can significantly improve healthspan and reduce mortality risk, it could lead to widely adopted, accessible interventions. This could translate into a healthier, more active senior population, potentially reducing healthcare burdens associated with age-related chronic diseases and frailty. The focus on improving cardiorespiratory fitness, a potent predictor of all-cause mortality, suggests a direct impact on longevity and quality of life. The multi-site nature of the study also enhances the credibility and potential for widespread clinical application of its results, moving beyond localized findings.
What's Next?
Recruitment for participation in the BOOST-X trial is anticipated to begin in late December 2026. The IHMC Study Participation website will provide future updates for those interested in joining. The ongoing M³AX trial is currently in its third year, and researchers are observing clinically significant improvements in cardiorespiratory fitness and functional muscle quality in many participants. The BOOST-X trial aims to further enhance these outcomes by introducing the nitrate adjuvant. If successful, the findings from BOOST-X could lead to new recommendations for exercise and dietary supplementation for older adults, potentially influencing public health guidelines and preventive care strategies. Future research will likely focus on the long-term effects of such interventions and their integration into broader healthcare systems.
Beyond the Headlines
The IHMC research delves into the deeper implications of how lifestyle interventions, potentially augmented by supplements, can fundamentally alter the aging process. The concept of 'healthspan'—the period of life spent in good health—is gaining increasing attention, moving beyond mere lifespan extension. This study highlights the ethical considerations of promoting interventions that could significantly impact the quality of later life, potentially shifting societal perceptions of aging from a period of decline to one of continued vitality. The use of a nitrate supplement, such as beetroot juice, also touches upon the intersection of nutrition and medicine, suggesting a future where dietary components are more actively integrated into therapeutic strategies. Furthermore, the emphasis on improving cognitive function alongside physical health underscores a holistic approach to healthy aging, recognizing the interconnectedness of various bodily systems.
